Therapeutic potential of melatonin in traumatic central nervous system injury

Supriti Samantaray, Arabinda Das, Nakul P. Thakore, Denise D. Matzelle, Russel J Reiter, Swapan K. Ray, Naren L. Banik

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

A vast literature extolling the benefits of melatonin has accumulated during the past four decades. Melatonin was previously considered of importance to seasonal reproduction and circadian rhythmicity. Currently, it appears to be a versatile anti-oxidative and anti-nitrosative agent, a molecule with immunomodulatory actions and profound oncostatic activity, and also to play a role as a potent neuroprotectant. Nowadays, melatonin is sold as a dietary supplement with differential availability as an over-the-counter aid in different countries. There is a widespread agreement that melatonin is nontoxic and safe considering its frequent, long-term usage by humans at both physiological and pharmacological doses with no reported side effects. Endeavors toward a designated drug status for melatonin may be enormously rewarding in clinics for treatment of several forms of neurotrauma where effective pharmacological intervention has not yet been attained. This mini review consolidates the data regarding the efficacy of melatonin as an unique neuroprotective agent in traumatic central nervous system (CNS) injuries. Well-documented actions of melatonin in combating traumatic CNS damage are compiled from various clinical and experimental studies. Research on traumatic brain injury and ischemia/reperfusion are briefly outlined here as they have been recently reviewed elsewhere, whereas the studies on different animal models of the experimental spinal cord injury have been extensively covered in this mini review for the first time.

Original languageEnglish (US)
Pages (from-to)134-142
Number of pages9
JournalJournal of Pineal Research
Volume47
Issue number2
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Nervous System Trauma
Melatonin
Central Nervous System
Neuroprotective Agents
Therapeutics
Pharmacology
Periodicity
Dietary Supplements
Brain Ischemia
Spinal Cord Injuries
Reperfusion
Reproduction
Animal Models
Research
Pharmaceutical Preparations

Keywords

  • Calpain
  • Melatonin
  • Melatonin receptors
  • Neurodegeneration
  • Spinal cord injury
  • Traumatic CNS injuries

ASJC Scopus subject areas

  • Endocrinology

Cite this

Samantaray, S., Das, A., Thakore, N. P., Matzelle, D. D., Reiter, R. J., Ray, S. K., & Banik, N. L. (2009). Therapeutic potential of melatonin in traumatic central nervous system injury. Journal of Pineal Research, 47(2), 134-142. https://doi.org/10.1111/j.1600-079X.2009.00703.x

Therapeutic potential of melatonin in traumatic central nervous system injury. / Samantaray, Supriti; Das, Arabinda; Thakore, Nakul P.; Matzelle, Denise D.; Reiter, Russel J; Ray, Swapan K.; Banik, Naren L.

In: Journal of Pineal Research, Vol. 47, No. 2, 09.2009, p. 134-142.

Research output: Contribution to journalArticle

Samantaray, S, Das, A, Thakore, NP, Matzelle, DD, Reiter, RJ, Ray, SK & Banik, NL 2009, 'Therapeutic potential of melatonin in traumatic central nervous system injury', Journal of Pineal Research, vol. 47, no. 2, pp. 134-142. https://doi.org/10.1111/j.1600-079X.2009.00703.x
Samantaray, Supriti ; Das, Arabinda ; Thakore, Nakul P. ; Matzelle, Denise D. ; Reiter, Russel J ; Ray, Swapan K. ; Banik, Naren L. / Therapeutic potential of melatonin in traumatic central nervous system injury. In: Journal of Pineal Research. 2009 ; Vol. 47, No. 2. pp. 134-142.
@article{bba0482a9e6b4ee6973112730fca20e8,
title = "Therapeutic potential of melatonin in traumatic central nervous system injury",
abstract = "A vast literature extolling the benefits of melatonin has accumulated during the past four decades. Melatonin was previously considered of importance to seasonal reproduction and circadian rhythmicity. Currently, it appears to be a versatile anti-oxidative and anti-nitrosative agent, a molecule with immunomodulatory actions and profound oncostatic activity, and also to play a role as a potent neuroprotectant. Nowadays, melatonin is sold as a dietary supplement with differential availability as an over-the-counter aid in different countries. There is a widespread agreement that melatonin is nontoxic and safe considering its frequent, long-term usage by humans at both physiological and pharmacological doses with no reported side effects. Endeavors toward a designated drug status for melatonin may be enormously rewarding in clinics for treatment of several forms of neurotrauma where effective pharmacological intervention has not yet been attained. This mini review consolidates the data regarding the efficacy of melatonin as an unique neuroprotective agent in traumatic central nervous system (CNS) injuries. Well-documented actions of melatonin in combating traumatic CNS damage are compiled from various clinical and experimental studies. Research on traumatic brain injury and ischemia/reperfusion are briefly outlined here as they have been recently reviewed elsewhere, whereas the studies on different animal models of the experimental spinal cord injury have been extensively covered in this mini review for the first time.",
keywords = "Calpain, Melatonin, Melatonin receptors, Neurodegeneration, Spinal cord injury, Traumatic CNS injuries",
author = "Supriti Samantaray and Arabinda Das and Thakore, {Nakul P.} and Matzelle, {Denise D.} and Reiter, {Russel J} and Ray, {Swapan K.} and Banik, {Naren L.}",
year = "2009",
month = "9",
doi = "10.1111/j.1600-079X.2009.00703.x",
language = "English (US)",
volume = "47",
pages = "134--142",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Therapeutic potential of melatonin in traumatic central nervous system injury

AU - Samantaray, Supriti

AU - Das, Arabinda

AU - Thakore, Nakul P.

AU - Matzelle, Denise D.

AU - Reiter, Russel J

AU - Ray, Swapan K.

AU - Banik, Naren L.

PY - 2009/9

Y1 - 2009/9

N2 - A vast literature extolling the benefits of melatonin has accumulated during the past four decades. Melatonin was previously considered of importance to seasonal reproduction and circadian rhythmicity. Currently, it appears to be a versatile anti-oxidative and anti-nitrosative agent, a molecule with immunomodulatory actions and profound oncostatic activity, and also to play a role as a potent neuroprotectant. Nowadays, melatonin is sold as a dietary supplement with differential availability as an over-the-counter aid in different countries. There is a widespread agreement that melatonin is nontoxic and safe considering its frequent, long-term usage by humans at both physiological and pharmacological doses with no reported side effects. Endeavors toward a designated drug status for melatonin may be enormously rewarding in clinics for treatment of several forms of neurotrauma where effective pharmacological intervention has not yet been attained. This mini review consolidates the data regarding the efficacy of melatonin as an unique neuroprotective agent in traumatic central nervous system (CNS) injuries. Well-documented actions of melatonin in combating traumatic CNS damage are compiled from various clinical and experimental studies. Research on traumatic brain injury and ischemia/reperfusion are briefly outlined here as they have been recently reviewed elsewhere, whereas the studies on different animal models of the experimental spinal cord injury have been extensively covered in this mini review for the first time.

AB - A vast literature extolling the benefits of melatonin has accumulated during the past four decades. Melatonin was previously considered of importance to seasonal reproduction and circadian rhythmicity. Currently, it appears to be a versatile anti-oxidative and anti-nitrosative agent, a molecule with immunomodulatory actions and profound oncostatic activity, and also to play a role as a potent neuroprotectant. Nowadays, melatonin is sold as a dietary supplement with differential availability as an over-the-counter aid in different countries. There is a widespread agreement that melatonin is nontoxic and safe considering its frequent, long-term usage by humans at both physiological and pharmacological doses with no reported side effects. Endeavors toward a designated drug status for melatonin may be enormously rewarding in clinics for treatment of several forms of neurotrauma where effective pharmacological intervention has not yet been attained. This mini review consolidates the data regarding the efficacy of melatonin as an unique neuroprotective agent in traumatic central nervous system (CNS) injuries. Well-documented actions of melatonin in combating traumatic CNS damage are compiled from various clinical and experimental studies. Research on traumatic brain injury and ischemia/reperfusion are briefly outlined here as they have been recently reviewed elsewhere, whereas the studies on different animal models of the experimental spinal cord injury have been extensively covered in this mini review for the first time.

KW - Calpain

KW - Melatonin

KW - Melatonin receptors

KW - Neurodegeneration

KW - Spinal cord injury

KW - Traumatic CNS injuries

UR - http://www.scopus.com/inward/record.url?scp=68249105603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249105603&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.2009.00703.x

DO - 10.1111/j.1600-079X.2009.00703.x

M3 - Article

VL - 47

SP - 134

EP - 142

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 2

ER -